Showing results (31-40 of 7,751) with videos related to

Sort By:
Pageof 776
Clinical Therapeutics|July 16, 2002
Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitisAntonio Anzueto, Mark Gotfried, Matthew A Wikler, et al.
Diagnostic Microbiology and Infectious Disease|July 16, 2008
Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strainsRonald N Jones, Douglas J Biedenbach, Paul G Ambrose, et al.
Pharmacology|January 1, 1977
Marijuana: dose-response effects on pulse rate, subjective estimates of potency, pleasantness, and recognition memoryL Miller, T Cornett, W Drew, et al.
Alcoholism, Clinical and Experimental Research|July 1, 1979
Similarity of effects of alcohol and sensory stimulation in post-alcoholics and controlsA M Ludwig, A Wikler, M Buchsbaum, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1976
Marijuana and memory impairment: the effect of retrieval cues on free recallL Miller, T Cornett, D Brightwell, et al.
Psychopharmacology|December 28, 1977
Marijuana: effects on free recall and subjective organization of pictures and wordsL L Miller, D J McFarland, T L Cornett, et al.
Diseases of the Nervous System|September 1, 1977
Alcoholics and high-low sensory input: a pilot studyA M Ludwig, A Wikler, R B Cain, et al.
Clinical Therapeutics|January 1, 1985
Clinical efficacy of cefonicid in the treatment of staphylococcal infectionsA L Lentnek, H M Evrard, M A Wikler, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
In vitro antimicrobial activity of doripenem, a new carbapenemYigong Ge, Matthew A Wikler, Daniel F Sahm, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenemSujata M Bhavnani, Jeffrey P Hammel, Brenda B Cirincione, et al.
Pageof 776